See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $417B | 4.9x | 17.7x | |
| $371B | 6.5x | 14.4x | |
| $204B | 4.3x | 18.1x | |
| $173B | 2.6x | 12.4x | |
| $83.7B | 4.2x | 16.8x | |
| $63.1B | 8.7x | 37.3x | |
| $56.3B | 1.1x | 5.3x | |
| $53.7B | 3.7x | 14.7x | |
| $52.9B | 2.7x | 13.1x | |
| $52.0B | 2.8x | 10.0x | |
| $50.0B | 3.2x | 13.7x | |
| $43.3B | 5.1x | 21.1x | |
| $29.3B | 1.3x | 7.1x | |
| $26.9B | 4.4x | 19.0x | |
| $26.7B | 1.8x | 13.4x | |
| $25.0B | 2.3x | 13.4x | |
| $22.7B | 5.1x | 22.1x | |
| $21.8B | 1.5x | 8.2x | |
| $21.7B | 2.2x | 6.5x | |
| $17.6B | 1.5x | 9.8x | |
| $17.0B | 1.6x | 10.7x | |
| $14.6B | 8.8x | 42.0x | |
| $12.2B | 2.2x | 16.0x | |
| $12.1B | 1.8x | 9.7x | |
| $10.8B | 7.5x | 28.6x | |
| $10.6B | 8.5x | 41.7x | |
| $10.1B | 1.9x | 9.7x | |
| $9.4B | 6.3x | 33.6x | |
| $8.3B | 10.1x | 23.3x | |
| $8.2B | 1.2x | 11.8x | |
| $8.1B | 1.3x | 7.3x | |
| $7.7B | 10.8x | 33.4x | |
| $6.4B | 1.5x | 8.8x | |
| $5.2B | 11.8x | 38.8x | |
| $5.1B | 9.9x | 41.4x | |
| $5.0B | 4.5x | 13.5x | |
| $4.6B | 1.4x | 7.8x | |
| $4.4B | 1.6x | 12.3x | |
| $3.9B | 1.6x | 7.3x | |
| $3.9B | 2.5x | 13.7x | |
| $3.4B | 2.3x | 11.2x | |
| $3.4B | 1.6x | 9.3x | |
| $3.3B | 2.5x | 11.2x | |
| $3.1B | 1.5x | 10.0x | |
| $3.0B | 6.8x | 24.6x | |
| $2.9B | 8.9x | 36.0x | |
| $2.9B | 0.9x | 5.6x | |
| $2.9B | 0.6x | 5.5x | |
| $2.9B | 3.0x | 13.3x | |
| $2.7B | 1.2x | 7.7x | |
| $2.7B | 0.6x | 5.6x | |
| $2.7B | 1.0x | 8.2x | |
| $2.5B | 2.5x | 16.9x | |
| $2.3B | 1.0x | 4.9x | |
| $2.3B | 1.1x | 9.4x | |
| $2.3B | 0.7x | 5.1x | |
| $2.2B | 3.3x | 14.7x | |
| $2.1B | 2.4x | 16.0x | |
| $2.1B | 1.9x | -51.7x | |
| $2.0B | 3.4x | 21.7x | |
| $1.8B | 1.0x | 8.7x | |
| $1.7B | 3.2x | 16.1x | |
| $1.7B | 4.4x | 12.4x | |
| $1.6B | 1.0x | 9.1x | |
| $1.6B | 0.7x | 8.1x | |
| $1.5B | 1.3x | 8.5x | |
| $1.5B | 0.8x | 5.1x | |
| $1.4B | 1.9x | 10.3x | |
| $1.4B | 2.8x | 13.7x | |
| $1.4B | n/a | n/a | |
| $1.4B | 0.7x | 6.1x | |
| $1.3B | 1.1x | 8.5x | |
| $1.2B | 2.2x | 8.5x | |
| $963M | 7.2x | 27.1x | |
| $916M | 1.4x | 5.6x | |
| $900M | 1.4x | 10.0x | |
| $862M | 2.0x | 7.3x | |
| $807M | 3.4x | 107.5x | |
| $713M | n/a | n/a | |
| $650M | 2.2x | -26.9x | |
| $633M | 0.9x | 4.6x | |
| $608M | n/a | n/a | |
| $607M | 1.4x | 6.4x | |
| $588M | 0.3x | n/a | |
| $541M | 0.8x | 5.7x | |
| $528M | 2.2x | 9.3x | |
| $467M | 1.6x | 10.6x | |
| $426M | n/a | n/a | |
| $426M | 1.1x | 16.0x | |
| $421M | 0.1x | 1.1x | |
| $394M | n/a | n/a | |
| $382M | 0.4x | 3.8x | |
| $368M | 1.0x | 6.7x | |
| $360M | 1.8x | -23.7x | |
| $359M | 2.5x | 10.1x | |
| $358M | n/a | n/a | |
| $342M | n/a | n/a | |
| $330M | 1.0x | 26.6x | |
| $286M | n/a | n/a | |
| $275M | 0.7x | 8.9x | |
| $269M | 2.1x | 6.7x | |
| $258M | n/a | n/a | |
| $214M | 0.9x | 11.2x | |
| $195M | 0.4x | 9.4x | |
| $191M | 1.0x | 6.4x | |
| $169M | 0.9x | 8.7x | |
| $157M | n/a | n/a | |
| $141M | 0.6x | 6.8x | |
| $138M | 0.5x | 6.0x | |
| $124M | 2.2x | 7.1x | |
| $117M | n/a | n/a | |
| $117M | 1.8x | 8.1x | |
| $108M | n/a | n/a | |
| $31.1M | 0.6x | 4.4x | |
| $27.7M | n/a | n/a | |
| $24.8M | n/a | n/a | |
| $19.5M | 0.9x | -37.1x | |
| $19.0M | n/a | n/a | |
| $17.7M | 1.4x | n/a | |
| $0.3M | n/a | n/a | |
| -$7.2M | -0.0x | -0.2x | |
| -$20.0M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty